Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Completed

Plain-English translation of NCT00979745 on ClinicalTrials.gov ↗ · Source last updated October 2021 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(8 sites)

Finland

HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital), Helsinki

France

Centre Français des Porphyries, Hôpital Louis Mourier, Colombes, Cedex

Germany

Department of Dermatology , Heinrich-Heine-University Duesseldorf, Düsseldorf

Ireland

Beaumont Hospital, Department of Dermatology, Dublin

Netherlands

Academisch Ziekenhuis Maastricht, Maastricht